"El Hospital Italiano Regional del Sur fue fundado el 7 de junio de 1964 en la ciudad de Bahía Blanca. Toda la información referida al Hospital y a los Servicios que brinda se puede encontrar en nuestro sitio web. Esto incluye los teléfonos de contacto, los Profesionales a cargo de los Servicios, información sobré cómo pedir turnos, reintegros, historias clínicas, etcétera, y también información sobre la cobertura de Obras Sociales. Cualquier información extra necesaria, por favor realícela por correo electrónico a info@hospitalitalianobb.com.ar. CVs a rrhh@hospitalitalianobb.com.ar."

During the past decade, Hospital Italiano Regional del Sur conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 11 clinical trials were completed, i.e. on average, 91.7% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 7 clinical trials were completed. i.e. 140% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Italiano Regional del Sur" #1 sponsor was "Boehringer Ingelheim" with 3 trials, followed by "Janssen Research & Development, LLC" with 2 trials sponsored, "Merck Sharp & Dohme LLC" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "R-Pharm International, LLC" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Italiano Regional del Sur" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "OCT Clinical Trials" with 2 trials as a collaborator, "Quintiles, Inc." with 2 trials as a collaborator and "Brigham and Women's Hospital" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Italiano Regional del Sur" are "Rheumatoid Arthritis" (3 trials), "Cardiovascular Disease" (2 trials), "Heart Failure" (2 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Carcinoma, Non-squamous Non-small-cell Lung" (1 trials). Many other conditions were trialed in "Hospital Italiano Regional del Sur" in a lesser frequency.

Most popular intervention types in "Hospital Italiano Regional del Sur" are "Drug" (20 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Carboplatin" (2 trials), "Empagliflozin" (2 trials), "Olaparib" (2 trials) and "Pembrolizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Italiano Regional del Sur" are 20 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Italiano Regional del Sur". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Hospital Italiano Regional del Sur, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Italiano Regional del Sur, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".